0001628280-23-003708.txt : 20230215
0001628280-23-003708.hdr.sgml : 20230215
20230215161943
ACCESSION NUMBER: 0001628280-23-003708
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Christopher Ryan
CENTRAL INDEX KEY: 0001810417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 23635624
MAIL ADDRESS:
STREET 1: C/O CERECOR INC.
STREET 2: 400 E. PRATT STREET, SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wf-form4_167649596254341.xml
FORM 4
X0306
4
2023-02-13
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001810417
Sullivan Christopher Ryan
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
2.98
2023-02-13
4
A
0
40000
0
A
2033-02-13
Common Stock
40000.0
40000
D
One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
/s/ Jennifer Zoltoski, by Power of Attorney
2023-02-15